Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Capsaicin in Digital Osteoarthritis Versus Control: A Randomized Study
2024-511159-16-00Phase 4Authorised
- Sponsor
- Centre Hospitalier Universitaire de Clermont-Ferrand
- Start
- May 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of capsaicin in osteoarthritis (OA) (2 arms), sponsored by Centre Hospitalier Universitaire de Clermont-Ferrand. Primary endpoint: Finger pain intensity at 8 weeks. Planned start May 2024; status: authorised.
02
Drugs
capsaicin
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on 2024-511159-16-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-511159-16-00.